Revelation Biosciences (REVB) Shares Outstanding (Diluted) (2021 - 2026)
Revelation Biosciences' Shares Outstanding (Diluted) was 3.83 million in Q2 2026, compared with 200,668 a year earlier and up 19.4% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Revelation Biosciences came in at 620,785.
- Shares Outstanding (Diluted) shows a four-year compound annual growth rate of 353.4% (FY2021 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 14,292 in FY2024, 1,191 in FY2023 (-57.6%), 2,807 in FY2022 (+91.1%) and 1,469 in FY2021.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2021.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q3 2024 (growth of 912.9%); the worst was Q2 2022 (a decline of 86.0%).
- Per Business Quant data, REVB's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 3.21 million (Q1 2026), 620,785 (Q4 2025) and 661,183 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | 3.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.83 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | 620,785.00 |
| Sep 30, 2025 | 661,183.00 |
| Jun 30, 2025 | 200,668.00 |
| Mar 31, 2025 | 80,942.00 |
| Dec 31, 2024 | 14,292.00 |
| Sep 30, 2024 | 13,958.00 |
| Jun 30, 2024 | 8,517.00 |
| Mar 31, 2024 | 5,676.00 |
| Dec 31, 2023 | 1,191.00 |
| Sep 30, 2023 | 1,378.00 |
| Jun 30, 2023 | 30,272.00 |
| Mar 31, 2023 | 16,333.00 |
| Dec 31, 2022 | 2,807.00 |
| Sep 30, 2022 | 3,187.00 |
| Jun 30, 2022 | 2,299.00 |
| Mar 31, 2022 | 2,168.00 |
| Dec 31, 2021 | 1,469.00 |
| Sep 30, 2021 | 11,043.00 |
API Access
Revelation Biosciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();